| 臺大學術典藏 |
2020-06-30T08:10:03Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng C.-H.;Chen K.-C.;Hsu K.-H.;Tseng J.-S.;Ho C.-C.;Hsia T.-C.;Kang-Yi Su;Wu M.-F.;Chiu K.-L.;Liu C.-M.;Wu T.-C.;Chen H.-J.;Chen H.-Y.;Chang C.-S.;Hsu C.-P.;Hsia J.-Y.;Chuang C.-Y.;Lin C.-H.;Chen J.J.W.;Chen K.-Y.;Liao W.-Y.;Shih J.-Y.;Yu S.-L.;Yu C.-J.;Yang P.-C.;Yang T.-Y.;Chang G.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; KANG-YI SU; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:10:02Z |
Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients
|
Huang Y.-H.;Hsu K.-H.;Tseng J.-S.;Chen K.-C.;Kang-Yi Su;Chen H.-Y.;Chang C.-S.;Chen J.J.W.;Yu S.-L.;Chen H.-W.;Yang T.-Y.;Chang G.-C.; Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; Yu S.-L.; Chen H.-W.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:10:00Z |
Small molecule T315 promotes casitas b-lineage lymphoma dependent degradation of epidermal growth factor receptor via Y1045 autophosphorylation
|
Huang K.-Y.;Kao S.-H.;Wang W.-L.;Chen C.-Y.;Hsiao T.-H.;Salunke S.B.;Chen J.J.W.;Kang-Yi Su;Yang S.-C.;Hong T.-M.;Chen C.-S.;Yang P.-C.; Huang K.-Y.; Kao S.-H.; Wang W.-L.; Chen C.-Y.; Hsiao T.-H.; Salunke S.B.; Chen J.J.W.; KANG-YI SU; Yang S.-C.; Hong T.-M.; Chen C.-S.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:59Z |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chen C.-H.;Chang W.-H.;Kang-Yi Su;Ku W.-H.;Chang G.-C.;Hong Q.-S.;Hsiao Y.-J.;Chen H.-C.;Chen H.-Y.;Wu R.;Yang P.-C.;Chen J.J.W.;Yu S.-L.; Chen C.-H.; Chang W.-H.; KANG-YI SU; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; Yang P.-C.; Chen J.J.W.; Yu S.-L. |
| 臺大學術典藏 |
2020-06-30T08:09:59Z |
Molecular gene signature and prognosis of non-small cell lung cancer
|
Huang P.;Cheng C.-L.;Chang Y.-H.;Liu C.-H.;Hsu Y.-C.;Chen J.-S.;Chang G.-C.;Ho B.-C.;Kang-Yi Su;Chen H.-Y.;Yu S.-L.; Huang P.; Cheng C.-L.; Chang Y.-H.; Liu C.-H.; Hsu Y.-C.; Chen J.-S.; Chang G.-C.; Ho B.-C.; KANG-YI SU; Chen H.-Y.; Yu S.-L. |
| 臺大學術典藏 |
2020-06-30T08:09:58Z |
Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients
|
Pan S.-H.;Kang-Yi Su;Spiessens B.;Kusuma N.;Delahaye N.F.;Gruselle O.;Myo A.;De Creus A.;Louahed J.;Chang G.-C.;Yu S.-L.;Yang P.-C.; Pan S.-H.; KANG-YI SU; Spiessens B.; Kusuma N.; Delahaye N.F.; Gruselle O.; Myo A.; de Creus A.; Louahed J.; Chang G.-C.; Yu S.-L.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:58Z |
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS
|
Kang-Yi Su;Yan B.-S.;Chiu H.-C.;Yu C.-J.;Chang S.-Y.;Jou R.;Liu J.-L.;Hsueh P.-R.;Yu S.-L.; KANG-YI SU; Yan B.-S.; Chiu H.-C.; Yu C.-J.; Chang S.-Y.; Jou R.; Liu J.-L.; Hsueh P.-R.; Yu S.-L. |
| 臺大學術典藏 |
2020-06-30T08:09:58Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng C.-H.;Chiang C.-J.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Ho C.-C.;Yu C.-J.;Tsai Y.-H.;Chen J.-S.;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Kang-Yi Su;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Liu T.-W.;Chang G.-C.; Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; KANG-YI SU; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Liu T.-W.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:57Z |
Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay
|
Lin L.-I.; Yang Y.-C.; Fang W.-H.; Kang-Yi Su;Lai H.-M.;Goodman S.D.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Fang W.-H.; KANG-YI SU; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:57Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Kang-Yi Su;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; KANG-YI SU; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:56Z |
FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression
|
Hsu C.-Y.;Chang G.-C.;Chen Y.-J.;Hsu Y.-C.;Hsiao Y.-J.;Kang-Yi Su;Chen H.-Y.;Lin C.-Y.;Chen J.-S.;Chen Y.-J.;Hong Q.-S.;Ku W.-H.;Wu C.-Y.;Ho B.-C.;Chiang C.-C.;Yang P.-C.;Yu S.-L.; Hsu C.-Y.; Chang G.-C.; Chen Y.-J.; Hsu Y.-C.; Hsiao Y.-J.; KANG-YI SU; Chen H.-Y.; Lin C.-Y.; Chen J.-S.; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; Yang P.-C.; Yu S.-L. |
| 臺大學術典藏 |
2020-06-30T08:09:56Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Kang-Yi Su;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; KANG-YI SU; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:55Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Huang Y.-H.;Hsu K.-H.;Tseng J.-S.;Chen K.-C.;Hsu C.-H.;Kang-Yi Su;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Yang T.-Y.;Chang G.-C.; Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Hsu C.-H.; KANG-YI SU; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:55Z |
Novel therapeutic drug identification and gene correlation for fatty liver disease using high-content screening: Proof of concept
|
Luo W.-J.;Cheng T.-Y.;Wong K.-I.;Fang W.-H.;Liao K.-M.;Hsieh Y.-T.;Kang-Yi Su; Luo W.-J.; Cheng T.-Y.; Wong K.-I.; Fang W.-H.; Liao K.-M.; Hsieh Y.-T.; KANG-YI SU |
| 臺大學術典藏 |
2020-06-30T08:09:55Z |
Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis
|
Kang-Yi Su;Goodman S.D.;Lai H.-M.;Yen R.-S.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Fang W.-H.; KANG-YI SU; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; Yang Y.-C.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:55Z |
DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo
|
Kang-Yi Su;Lin L.-I.;Goodman S.D.;Yen R.-S.;Wu C.-Y.;Chang W.-C.;Yang Y.-C.;Cheng W.-C.;Fang W.-H.; KANG-YI SU; Lin L.-I.; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; Yang Y.-C.; Cheng W.-C.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:53Z |
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment na?ve advanced EGFR-mutant lung adenocarcinoma patients
|
Hsu K.-H.;Huang Y.-H.;Tseng J.-S.;Chen K.-C.;Ku W.-H.;Kang-Yi Su;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Yang T.-Y.;Chang G.-C.; Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; KANG-YI SU; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:53Z |
Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation
|
Kang-Yi Su;Li M.-C.;Lee N.-W.;Ho B.-C.;Cheng C.-L.;Chuang Y.-C.;Yu S.-L.;Guo Y.L.; KANG-YI SU; Li M.-C.; Lee N.-W.; Ho B.-C.; Cheng C.-L.; Chuang Y.-C.; Yu S.-L.; Guo Y.L. |
| 臺大學術典藏 |
2020-06-30T08:09:52Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:52Z |
Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice
|
Wu S.-L.;Wei T.-Y.;Lin S.-W.;Kang-Yi Su;Kuo C.-H.; Wu S.-L.; Wei T.-Y.; Lin S.-W.; KANG-YI SU; Kuo C.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:51Z |
Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay
|
Chang H.-L.;Kang-Yi Su;Goodman S.D.;Chou N.-A.;Lin K.-C.;Cheng W.-C.;Lin L.-I.;Chang S.-Y.;Fang W.-H.; Chang H.-L.; KANG-YI SU; Goodman S.D.; Chou N.-A.; Lin K.-C.; Cheng W.-C.; Lin L.-I.; Chang S.-Y.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:51Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-04-08T10:35:55Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chia-Chi Hsu; Bin-Chi Liao; Wei-Hsun Hsu; Jih-Hsiang Lee; Chia-Chi Lin; Jin-Yuan Shih; James C.-H. Yang; Chong-Jen Yu; Ching-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chong-Jen Yu;James C.-H. Yang;Jin-Yuan Shih;Chia-Chi Lin;Jih-Hsiang Lee;Wei-Hsun Hsu;Bin-Chi Liao;Chia-Chi Hsu;Chen-Tu Wu;Yih-Leong Chang;Kang-Yi Su;Chia-Lin Hsu;Tzu-Hsiu Tsai;Kuan-Yu Chen;Chao-Chi Ho;Wei-Yu Liao;Ching-Yao Yang |
| 臺大學術典藏 |
2019-11-08T03:15:57Z |
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Hsu, Chia-Hung; KANG-YI SU; Chen, Jeremy J W; HUEI-WEN CHEN; SUNG-LIANG YU; Yang, Tsung-Ying; Chang, Gee-Chen; Huang, Yen-Hsiang;Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Chen, Kun-Chieh;Hsu, Chia-Hung;Kang-Yi Su;Chen, Jeremy J W;Huei-Wen Chen;Sung-Liang Yu;Yang, Tsung-Ying;Chang, Gee-Chen |
| 臺大學術典藏 |
2019-04-17T07:12:36Z |
R26R-GR: a Cre-activable dual fluorescent protein reporter mouse
|
Yu, I-Shing;Chien, Chung-Liang;Fan, Hsiang-Hsuan;Huang, Cheng-Yen;Tsai, Ming-Shian;SHU-WHA LIN;Nicolis, Silvia K.;Favaro, Rebecca;Behringer, Richard R.;Jang, Chuan-Wei;Su, I-Chang;KANG-YI SU;Hsu, Yu-Chen;Lin, Chang-Ching;Wang, Wei-Le;Yen, Shuo-Ting;JIN-BON HONG;Chou, Fu-Ju;Huang, Ke-Han;Ku, Amy Tsu;TSUNG-LIN YANG;You-Tzung Chen; You-Tzung Chen; Tsai, Ming-Shian; TSUNG-LIN YANG; Ku, Amy Tsu; Huang, Ke-Han; Huang, Cheng-Yen; Chou, Fu-Ju; Fan, Hsiang-Hsuan; JIN-BON HONG; Yen, Shuo-Ting; Wang, Wei-Le; Lin, Chang-Ching; Hsu, Yu-Chen; KANG-YI SU; Su, I-Chang; Jang, Chuan-Wei; Behringer, Richard R.; Favaro, Rebecca; Nicolis, Silvia K.; Chien, Chung-Liang; SHU-WHA LIN; Yu, I-Shing |
